Mast Cell Tumor Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: M11D5B95D55AEN
Market Monitor Global

Abstracts

Mast cell tumor (Mastocytoma) is formed by aggregation of number of mast cells to form big cist like structure. It is a type of rare disease usually seen in infants aged from 0 to 3 months and rarely diagnosed in adults.

This report contains market size and forecasts of Mast Cell Tumor Drugs in Global, including the following market information:

Global Mast Cell Tumor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mast Cell Tumor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mast Cell Tumor Drugs include Pfizer, Bausch Health Companies, Mylan, Teva, Johnson & Johnson, Sanofi, Bayer, Novartis and EPI Health. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mast Cell Tumor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mast Cell Tumor Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mast Cell Tumor Drugs Market Segment Percentages, by Type, 2021 (%)

• Topical Drug
• Oral Drug
• Injectable Drug

Global Mast Cell Tumor Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mast Cell Tumor Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Mast Cell Tumor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mast Cell Tumor Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mast Cell Tumor Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mast Cell Tumor Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Bausch Health Companies
• Mylan
• Teva
• Johnson & Johnson
• Sanofi
• Bayer
• Novartis
• EPI Health

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mast Cell Tumor Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mast Cell Tumor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MAST CELL TUMOR DRUGS OVERALL MARKET SIZE

2.1 Global Mast Cell Tumor Drugs Market Size: 2021 VS 2028
2.2 Global Mast Cell Tumor Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mast Cell Tumor Drugs Players in Global Market
3.2 Top Global Mast Cell Tumor Drugs Companies Ranked by Revenue
3.3 Global Mast Cell Tumor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Mast Cell Tumor Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mast Cell Tumor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mast Cell Tumor Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Mast Cell Tumor Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mast Cell Tumor Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mast Cell Tumor Drugs Market Size Markets, 2021 & 2028
  4.1.2 Topical Drug
  4.1.3 Oral Drug
  4.1.4 Injectable Drug
4.2 By Type - Global Mast Cell Tumor Drugs Revenue & Forecasts
  4.2.1 By Type - Global Mast Cell Tumor Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Mast Cell Tumor Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mast Cell Tumor Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Mast Cell Tumor Drugs Revenue & Forecasts
  5.2.1 By Application - Global Mast Cell Tumor Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Mast Cell Tumor Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mast Cell Tumor Drugs Market Size, 2021 & 2028
6.2 By Region - Global Mast Cell Tumor Drugs Revenue & Forecasts
  6.2.1 By Region - Global Mast Cell Tumor Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Mast Cell Tumor Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mast Cell Tumor Drugs Revenue, 2017-2028
  6.3.2 US Mast Cell Tumor Drugs Market Size, 2017-2028
  6.3.3 Canada Mast Cell Tumor Drugs Market Size, 2017-2028
  6.3.4 Mexico Mast Cell Tumor Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mast Cell Tumor Drugs Revenue, 2017-2028
  6.4.2 Germany Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.3 France Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.4 U.K. Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.5 Italy Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.6 Russia Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Mast Cell Tumor Drugs Market Size, 2017-2028
  6.4.8 Benelux Mast Cell Tumor Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mast Cell Tumor Drugs Revenue, 2017-2028
  6.5.2 China Mast Cell Tumor Drugs Market Size, 2017-2028
  6.5.3 Japan Mast Cell Tumor Drugs Market Size, 2017-2028
  6.5.4 South Korea Mast Cell Tumor Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Mast Cell Tumor Drugs Market Size, 2017-2028
  6.5.6 India Mast Cell Tumor Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mast Cell Tumor Drugs Revenue, 2017-2028
  6.6.2 Brazil Mast Cell Tumor Drugs Market Size, 2017-2028
  6.6.3 Argentina Mast Cell Tumor Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mast Cell Tumor Drugs Revenue, 2017-2028
  6.7.2 Turkey Mast Cell Tumor Drugs Market Size, 2017-2028
  6.7.3 Israel Mast Cell Tumor Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Mast Cell Tumor Drugs Market Size, 2017-2028
  6.7.5 UAE Mast Cell Tumor Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Mast Cell Tumor Drugs Major Product Offerings
  7.1.4 Pfizer Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Bausch Health Companies
  7.2.1 Bausch Health Companies Corporate Summary
  7.2.2 Bausch Health Companies Business Overview
  7.2.3 Bausch Health Companies Mast Cell Tumor Drugs Major Product Offerings
  7.2.4 Bausch Health Companies Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.2.5 Bausch Health Companies Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Mast Cell Tumor Drugs Major Product Offerings
  7.3.4 Mylan Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Teva
  7.4.1 Teva Corporate Summary
  7.4.2 Teva Business Overview
  7.4.3 Teva Mast Cell Tumor Drugs Major Product Offerings
  7.4.4 Teva Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.4.5 Teva Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Mast Cell Tumor Drugs Major Product Offerings
  7.5.4 Johnson & Johnson Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Mast Cell Tumor Drugs Major Product Offerings
  7.6.4 Sanofi Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.6.5 Sanofi Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Mast Cell Tumor Drugs Major Product Offerings
  7.7.4 Bayer Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.7.5 Bayer Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Mast Cell Tumor Drugs Major Product Offerings
  7.8.4 Novartis Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 EPI Health
  7.9.1 EPI Health Corporate Summary
  7.9.2 EPI Health Business Overview
  7.9.3 EPI Health Mast Cell Tumor Drugs Major Product Offerings
  7.9.4 EPI Health Mast Cell Tumor Drugs Revenue in Global Market (2017-2022)
  7.9.5 EPI Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mast Cell Tumor Drugs Market Opportunities & Trends in Global Market
Table 2. Mast Cell Tumor Drugs Market Drivers in Global Market
Table 3. Mast Cell Tumor Drugs Market Restraints in Global Market
Table 4. Key Players of Mast Cell Tumor Drugs in Global Market
Table 5. Top Mast Cell Tumor Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mast Cell Tumor Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mast Cell Tumor Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mast Cell Tumor Drugs Product Type
Table 9. List of Global Tier 1 Mast Cell Tumor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mast Cell Tumor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mast Cell Tumor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mast Cell Tumor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mast Cell Tumor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mast Cell Tumor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mast Cell Tumor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mast Cell Tumor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mast Cell Tumor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mast Cell Tumor Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mast Cell Tumor Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mast Cell Tumor Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mast Cell Tumor Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mast Cell Tumor Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mast Cell Tumor Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mast Cell Tumor Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Mast Cell Tumor Drugs Product Offerings
Table 32. Pfizer Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Bausch Health Companies Corporate Summary
Table 34. Bausch Health Companies Mast Cell Tumor Drugs Product Offerings
Table 35. Bausch Health Companies Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Mast Cell Tumor Drugs Product Offerings
Table 38. Mylan Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Mast Cell Tumor Drugs Product Offerings
Table 41. Teva Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Mast Cell Tumor Drugs Product Offerings
Table 44. Johnson & Johnson Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Mast Cell Tumor Drugs Product Offerings
Table 47. Sanofi Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Mast Cell Tumor Drugs Product Offerings
Table 50. Bayer Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Mast Cell Tumor Drugs Product Offerings
Table 53. Novartis Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)
Table 54. EPI Health Corporate Summary
Table 55. EPI Health Mast Cell Tumor Drugs Product Offerings
Table 56. EPI Health Mast Cell Tumor Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mast Cell Tumor Drugs Segment by Type in 2021
Figure 2. Mast Cell Tumor Drugs Segment by Application in 2021
Figure 3. Global Mast Cell Tumor Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mast Cell Tumor Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mast Cell Tumor Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mast Cell Tumor Drugs Revenue in 2021
Figure 8. By Type - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 12. US Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 24. China Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mast Cell Tumor Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mast Cell Tumor Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bausch Health Companies Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. EPI Health Mast Cell Tumor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)